The amfAR Institute for HIV Cure Research is established with a $20 million grant over five years to the University of California, San Francisco. The Institute will serve as the cornerstone of amfAR’s Countdown to a Cure for AIDS initiative.
The “Undetectable=Untransmittable (U=U)” slogan is launched by the Prevention Access Campaign to promote the finding that HIV-positive people who are virally suppressed cannot sexually transmit the virus to others.
A large international study reports that HIV resistance to the widely prescribed antiretroviral drug tenofovir is becoming increasingly common.
At CROI, researchers announce that a man taking the HIV prevention pill Truvada has contracted HIV—the first reported infection of someone regularly taking the drug.
The U.S. Department of Health and Human Services releases new guidance for state, local, tribal, and territorial health departments that will allow them to request permission to use federal funds to support syringe services programs.
The United Nations holds its 2016 High-Level Meeting on Ending AIDS. UN member states pledge to end the AIDS epidemic by 2030, but the meeting is marked by controversy after more than 50 nations block the participation of groups representing LGBT people from attending the meeting.
